Onfolio Holdings, Inc. announced that On October 31, 2023, Rob te Braake tendered his resignation as the Interim Chief Financial Officer of the company effective November 1, 2023. Mr. te. Braake?

departure was not the result of any disagreement with the Company nor any issue related to the Company?s financial statements or accounting practices. Mr. te Braake was serving as the Company?s Interim Chief Financial Officer until the Company appointed a permanent Chief Financial Officer. Mr. te Braake is expected to once again serve the Company as its financial advisor, which is the role he served in prior to his appointment as the Company?s Interim Chief Financial Officer.

On November 6, 2023, Esbe van Heerden, the Company?s President, was appointed by the Company?s Board of Directors to also serve as the Company?s Chief Financial Officer effective November 1, 2023. As the Company?s Chief Financial Officer, Ms. van Heerden will be responsible for analyzing budget and finances; creating and presenting financial and tax strategy recommendations to the executive team; overseeing cash flow, cash management, working capital, and company audits; preparing financial statements and reports, including SEC filings; ensuring legal compliance on all financial functions; other duties as may be prescribed by the Company?s Chief Executive Officer from time to time. Esbe van Heerden, age 31, has served as President since February 1, 2022, where she is responsible for implementing and developing Company?s shorter term business strategy and Company?s budgeting and performance tracking.

Previously, she served as Chief Operations Officer from August 2020 to January 31, 2022, and as Chief Operations Officer of Onfolio LLC since May 2019. During her time at Company, Ms. van Heerden has overseen an expansion from five team members, to 32, and monthly recuring revenue (MRR) growth of more than 700%. She joined Company after successfully building a boutique publishing house, NonFiction LLC, that helped CEOs and consultants succeed in publishing their books.

From June 2016 to December 2018, Ms. van Heerden built out the systems to guide new authors through the writing and publishing process, and grew to a team of 15+ staff members. Ms. van Heerden completed a triple major: a BSc in Biomedical Science, a BSc in Molecular Biology, as well as a BS in Forensic Biology and Toxicology, and was awarded the Vice-Chancellor?s Commendation for Academic Excellence. She graduated in 2015 from Murdoch University, Australia.